Our preliminary results showed that Rack1 level was significantly (p < 0.05) higher in newly diagnosed T-ALL patients than healthy control, while there was no obvious difference between T-ALL in remission and healthy control (Fig. 5c). Here, RACK1 is linked to acute lymphoblastic leukemia.